삼성서울병원

Ko En

Radiation Oncology Pyo, Hong Ryul M.D

Expertise
Lung cancer, prostate cancer, bladder cancer, thoracic malignancies, genito-urinary malignancies, proton therapy
Treament Schedule 06 月
DATE
SAT
01
SUN
02
MON
03
TUE
04
WEB
05
THU
06
FRI
07
SAT
08
SUN
09
MON
10
TUE
11
WEB
12
THU
13
FRI
14
SAT
15
SUN
16
MON
17
TUE
18
WEB
19
THU
20
FRI
21
SAT
22
SUN
23
MON
24
TUE
25
WEB
26
THU
27
FRI
28
SAT
29
SUN
30
AM
PM
Treament Schedule 07 月
DATE
MON
01
TUE
02
WEB
03
THU
04
FRI
05
SAT
06
SUN
07
MON
08
TUE
09
WEB
10
THU
11
FRI
12
SAT
13
SUN
14
MON
15
TUE
16
WEB
17
THU
18
FRI
19
SAT
20
SUN
21
MON
22
TUE
23
WEB
24
THU
25
FRI
26
SAT
27
SUN
28
MON
29
TUE
30
WEB
31
AM
PM

Medical Education

2002~2005 Ph.D. in Medicine Department of Medical Science, the graduate school, Chungnam University, Korea
1992~1994 Master of Medicine Department of Medical Science, the graduate school, Yonsei University, Korea
1984~1990 Medical Doctor Yonsei University College of Medicine, Korea

Post-Graduate Training

Fellowship   1998~1998 Department of Radiation Oncology, Yonsei University College of Medicine, Korea
Residency   1991~1995 Department of Radiation Oncology, Yonsei University College of Medicine, Korea
Internship   1990~1991 Severance Hospital, Yonsei University College of Medicine, Korea

Professional Appointments

2019~2021 Chair, Department of Radiation Oncology, Samsung Medical Center, Korea
2017~2019 Director, Proton Therapy Center, Samsung Medical Center, Korea
2012~2014 Visiting professor, Department of Radiation Oncology, University of North Carolina School of Medicine, NC, USA
2010~Present Professor, Department of Radiation Oncology, Samsung Medical Center, Korea
2009~2010 Chief Scientist and Radiation Oncologist, Proton Therapy Center, Center for Lung Cancer, National Cancer Center, Korea
2003~2009 Senior Scientist and Radiation Oncologist, Proton Therapy Center, Center for Lung Cancer, National Cancer Center, Korea
2001~2003 Assistant Professor, Department of Radiation Oncology, Yonsei University College of Medicine, Korea
1998~2001 Research fellow, Department of Radiation Oncology, Vanderbilt University Medical Center, TN, USA

Professional Memberships

2005 : American Association for Cancer Research
1995 : Korean Society for Radiation Oncology
1991: Korean Association for Radiation Protection
1991 : Korean Society for Head and Neck Oncology
1991 : Korean Cancer Association
1990 : Korean Medical Association

Selected Publications

  • J BONE ONCOL 2021 10.1016/j.jbo.2021.100368 Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases Kim1, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS
    View PubMed
  • RADIOTHER ONCOL 2021 10.1016/j.radonc.2020.12.019 Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy Kim1, N; Noh, JM; Lee, W; Park, B; Park, H; Park, JY; Pyo, H
    View PubMed
  • J THORAC DIS 2020 10.21037/jtd-20-667 Treatment modality and outcomes among early-stage non-small cell lung cancer patients with COPD a cohort study Kang1, N; Shin, SH; Noh, JM; Kang, D; Kim, H; Kwon, OJ; Pyo, H; Ahn, YC; Kim, HK; Choi, YS; Kim, J; Zo, JI; Shim, YM; Cho, J; Park, HY
    View PubMed
  • LUNG CANCER 2020 10.1016/j.lungcan.2020.05.035 Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer Jung1, HA; Noh, JM; Sun, JM; Lee, SH; Ahn, JS; Ahn, MJ; Pyo, H; Ahn, YC; Park, K
    View PubMed
  • Journal of thoracic disease 2020 10.21037/jtd.2020.03.23 Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgery Shin1, S; Kim, HK; Cho, JH; Choi, YS; Kim, K; Kim, J; Zo, JI; Sun, JM; Ahn, MJ; Park, K; Pyo, H; Ahn, YC; Shim, YM
    View PubMed